Dr Martin Ashby

Laboratory Technician

Martin Ashby completed his PhD at St. Georges University, London, in 2017. The title of his thesis was “The development of computer-designed and naturally occurring antimicrobial peptides to target methicillin-resistant Staphylococcus aureus (MRSA) using SPOT peptide synthesis”. During his studies he developed skills in various microbiology and peptide chemistry techniques.

In January 2018, Martin began working as a laboratory technician in the Non-Vesicular disease Reference Laboratory. Operating under ISO 17025 his work includes the use of PCR and ELISA diagnostic assays for bluetongue virus (BTV) and African horse sickness virus (AHSV), among others.

Publications
Conferences

Flannery J, Sanz-Bernardo B, Ashby M, Brown H, Carpenter S, Cooke L, Corla A, Frost L, Gubbins S, Hicks H, Qureshi M, Rajko-Nenow P, Sanders C, Tully M, Bréard E, Sailleau C, Zientara S, Darpel K, Batten C (2019)

Evidence of reduced viremia, pathogenicity and vector competence in a re-emerging European strain of bluetongue virus serotype 8 in sheep

Transboundary and Emerging Diseases 66 (3) , 1177-1185

Publisher’s version: https://doi.org/10.1111/tbed.13131

Ashby, M. Speaker, International Meeting on Antimicrobial Peptides, 2016

Ashby, M. Speaker, Society for applied microbiology. Antimicrobial resistance meeting, 2016

Groups

Non-Vesicular Reference Laboratory

Dr Martin Ashby

Evidence of reduced viremia, pathogenicity and vector competence in a re-emerging European strain of bluetongue virus serotype 8 in sheep

Trim content

You are here

Groups

Non-Vesicular Reference Laboratory

Dr Martin Ashby

Evidence of reduced viremia, pathogenicity and vector competence in a re-emerging European strain of bluetongue virus serotype 8 in sheep

Trim content